EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) Stock Competitors & Peer Comparison
See FOCL's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for FOCL and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FOCL | $5.44 | +0.00% | 203.7M | -6.99 | -$0.78 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $100.68 | +1.87% | 175.3B | 19.32 | $5.21 | +2.48% |
| ISRG | $345.42 | -11.20% | 142.5B | 41.82 | $9.62 | N/A |
| SYK | $319.87 | -3.42% | 122.6B | 23.89 | $13.39 | +1.09% |
| MDT | $83.20 | -0.43% | 106.5B | 15.04 | $5.53 | +3.43% |
| BSX | $44.03 | -1.32% | 65.4B | 14.20 | $3.10 | N/A |
| EW | $85.73 | -2.40% | 49.4B | 31.75 | $2.70 | N/A |
| DXCM | $76.65 | -1.71% | 29.6B | 32.90 | $2.33 | N/A |
| RMD | $198.99 | -1.86% | 28.9B | 18.47 | $10.77 | +1.21% |
Stock Comparison
Boston Scientific Corporation (NYSE: BSX-PA)
FOCL vs BSX-PA Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, FOCL's ROE is -1.38%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, FOCL is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BSX-PA's competition here
Abbott Laboratories (NYSE: ABT)
FOCL vs ABT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ABT has a market cap of 175.3B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ABT trades at $100.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ABT's P/E ratio is 19.32. In terms of profitability, FOCL's ROE is -1.38%, compared to ABT's ROE of +0.12%. Regarding short-term risk, FOCL is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ABT's competition here
Intuitive Surgical, Inc. (NASDAQ: ISRG)
FOCL vs ISRG Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ISRG has a market cap of 142.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ISRG trades at $345.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ISRG's P/E ratio is 41.82. In terms of profitability, FOCL's ROE is -1.38%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, FOCL is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ISRG's competition here
Stryker Corporation (NYSE: SYK)
FOCL vs SYK Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SYK has a market cap of 122.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SYK trades at $319.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SYK's P/E ratio is 23.89. In terms of profitability, FOCL's ROE is -1.38%, compared to SYK's ROE of +0.15%. Regarding short-term risk, FOCL is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SYK's competition here
Medtronic plc (NYSE: MDT)
FOCL vs MDT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, MDT has a market cap of 106.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while MDT trades at $83.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas MDT's P/E ratio is 15.04. In terms of profitability, FOCL's ROE is -1.38%, compared to MDT's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check MDT's competition here
Boston Scientific Corporation (NYSE: BSX)
FOCL vs BSX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BSX has a market cap of 65.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BSX trades at $44.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BSX's P/E ratio is 14.20. In terms of profitability, FOCL's ROE is -1.38%, compared to BSX's ROE of +0.15%. Regarding short-term risk, FOCL is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
FOCL vs EW Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, EW has a market cap of 49.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while EW trades at $85.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas EW's P/E ratio is 31.75. In terms of profitability, FOCL's ROE is -1.38%, compared to EW's ROE of +0.11%. Regarding short-term risk, FOCL is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
FOCL vs DXCM Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while DXCM trades at $76.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas DXCM's P/E ratio is 32.90. In terms of profitability, FOCL's ROE is -1.38%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, FOCL is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check DXCM's competition here
ResMed Inc. (NYSE: RMD)
FOCL vs RMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, RMD has a market cap of 28.9B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while RMD trades at $198.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas RMD's P/E ratio is 18.47. In terms of profitability, FOCL's ROE is -1.38%, compared to RMD's ROE of +0.24%. Regarding short-term risk, FOCL is more volatile compared to RMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check RMD's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
FOCL vs ZBH Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ZBH has a market cap of 17.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ZBH trades at $91.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ZBH's P/E ratio is 10.75. In terms of profitability, FOCL's ROE is -1.38%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, FOCL is less volatile compared to ZBH. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
FOCL vs ABMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ABMD's P/E ratio is 65.36. In terms of profitability, FOCL's ROE is -1.38%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, FOCL is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ABMD's competition here
Smith & Nephew plc (NYSE: SNN)
FOCL vs SNN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SNN has a market cap of 12.9B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SNN trades at $30.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SNN's P/E ratio is 16.53. In terms of profitability, FOCL's ROE is -1.38%, compared to SNN's ROE of +0.12%. Regarding short-term risk, FOCL is less volatile compared to SNN. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
FOCL vs ALGN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ALGN has a market cap of 12.7B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ALGN trades at $176.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ALGN's P/E ratio is 16.11. In terms of profitability, FOCL's ROE is -1.38%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, FOCL is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ALGN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
FOCL vs SWAV Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SWAV's P/E ratio is 78.76. In terms of profitability, FOCL's ROE is -1.38%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, FOCL is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SWAV's competition here
Penumbra, Inc. (NYSE: PEN)
FOCL vs PEN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PEN has a market cap of 12.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PEN trades at $318.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PEN's P/E ratio is 83.11. In terms of profitability, FOCL's ROE is -1.38%, compared to PEN's ROE of +0.12%. Regarding short-term risk, FOCL is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check PEN's competition here
Insulet Corp. (NASDAQ: PODD)
FOCL vs PODD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PODD has a market cap of 11.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PODD trades at $164.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PODD's P/E ratio is 30.49. In terms of profitability, FOCL's ROE is -1.38%, compared to PODD's ROE of +0.21%. Regarding short-term risk, FOCL is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
FOCL vs GMED Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, GMED has a market cap of 10.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while GMED trades at $77.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas GMED's P/E ratio is 17.34. In terms of profitability, FOCL's ROE is -1.38%, compared to GMED's ROE of +0.13%. Regarding short-term risk, FOCL is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
FOCL vs MASI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas MASI's P/E ratio is 44.43. In terms of profitability, FOCL's ROE is -1.38%, compared to MASI's ROE of +0.09%. Regarding short-term risk, FOCL is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check MASI's competition here
Glaukos Corporation (NYSE: GKOS)
FOCL vs GKOS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, GKOS has a market cap of 9.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while GKOS trades at $156.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas GKOS's P/E ratio is -182.44. In terms of profitability, FOCL's ROE is -1.38%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, FOCL is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check GKOS's competition here
Bruker Corporation (NASDAQ: BRKR)
FOCL vs BRKR Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BRKR has a market cap of 8.9B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BRKR trades at $58.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BRKR's P/E ratio is 31.99. In terms of profitability, FOCL's ROE is -1.38%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, FOCL is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BRKR's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
FOCL vs BIO-B Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BIO-B has a market cap of 8.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BIO-B trades at $324.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BIO-B's P/E ratio is 96.41. In terms of profitability, FOCL's ROE is -1.38%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, FOCL is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
FOCL vs BIO Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BIO has a market cap of 8.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BIO trades at $304.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BIO's P/E ratio is 32.81. In terms of profitability, FOCL's ROE is -1.38%, compared to BIO's ROE of +0.02%. Regarding short-term risk, FOCL is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check BIO's competition here
Inari Medical, Inc. (NASDAQ: NARI)
FOCL vs NARI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas NARI's P/E ratio is -59.24. In terms of profitability, FOCL's ROE is -1.38%, compared to NARI's ROE of -0.00%. Regarding short-term risk, FOCL is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NARI's competition here
LivaNova PLC (NASDAQ: LIVN)
FOCL vs LIVN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, LIVN has a market cap of 4.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while LIVN trades at $80.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas LIVN's P/E ratio is 20.18. In terms of profitability, FOCL's ROE is -1.38%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, FOCL is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check LIVN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
FOCL vs IRTC Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, IRTC has a market cap of 3.8B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while IRTC trades at $110.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas IRTC's P/E ratio is -205.98. In terms of profitability, FOCL's ROE is -1.38%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, FOCL is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
FOCL vs AXNX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AXNX's P/E ratio is -709.80. In terms of profitability, FOCL's ROE is -1.38%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AXNX's competition here
Integer Holdings Corporation (NYSE: ITGR)
FOCL vs ITGR Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ITGR has a market cap of 3.4B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ITGR trades at $95.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ITGR's P/E ratio is 15.81. In terms of profitability, FOCL's ROE is -1.38%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, FOCL is less volatile compared to ITGR. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ITGR's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
FOCL vs ESTA Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ESTA has a market cap of 2.7B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ESTA trades at $92.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ESTA's P/E ratio is -64.29. In terms of profitability, FOCL's ROE is -1.38%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, FOCL is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ESTA's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
FOCL vs TMDX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, TMDX has a market cap of 2.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while TMDX trades at $73.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas TMDX's P/E ratio is 30.20. In terms of profitability, FOCL's ROE is -1.38%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, FOCL is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
FOCL vs AXGN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AXGN has a market cap of 2.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AXGN trades at $39.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AXGN's P/E ratio is 104.87. In terms of profitability, FOCL's ROE is -1.38%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, FOCL is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check AXGN's competition here
NuVasive, Inc. (NASDAQ: NUVA)
FOCL vs NUVA Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas NUVA's P/E ratio is 75.00. In terms of profitability, FOCL's ROE is -1.38%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, FOCL is less volatile compared to NUVA. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check NUVA's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
FOCL vs UFPT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, UFPT has a market cap of 1.9B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while UFPT trades at $242.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas UFPT's P/E ratio is 25.21. In terms of profitability, FOCL's ROE is -1.38%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, FOCL is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check UFPT's competition here
Novocure Ltd (NASDAQ: NVCR)
FOCL vs NVCR Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while NVCR trades at $15.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas NVCR's P/E ratio is -10.41. In terms of profitability, FOCL's ROE is -1.38%, compared to NVCR's ROE of -0.51%. Regarding short-term risk, FOCL is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check NVCR's competition here
Butterfly Network, Inc. (NYSE: BFLY)
FOCL vs BFLY Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BFLY trades at $6.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BFLY's P/E ratio is -27.54. In terms of profitability, FOCL's ROE is -1.38%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, FOCL is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
FOCL vs ENOV Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ENOV trades at $27.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ENOV's P/E ratio is 8.01. In terms of profitability, FOCL's ROE is -1.38%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, FOCL is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ENOV's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
FOCL vs IART Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, IART has a market cap of 1.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while IART trades at $19.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas IART's P/E ratio is 8.41. In terms of profitability, FOCL's ROE is -1.38%, compared to IART's ROE of -0.48%. Regarding short-term risk, FOCL is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check IART's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
FOCL vs AHCO Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AHCO has a market cap of 1.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AHCO trades at $10.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AHCO's P/E ratio is 24.91. In terms of profitability, FOCL's ROE is -1.38%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, FOCL is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AHCO's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
FOCL vs INSP Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, INSP has a market cap of 1.5B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while INSP trades at $50.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas INSP's P/E ratio is 19.97. In terms of profitability, FOCL's ROE is -1.38%, compared to INSP's ROE of +0.18%. Regarding short-term risk, FOCL is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check INSP's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
FOCL vs ATEC Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ATEC trades at $8.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ATEC's P/E ratio is -77.59. In terms of profitability, FOCL's ROE is -1.38%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, FOCL is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ATEC's competition here
Heska Corporation (NASDAQ: HSKA)
FOCL vs HSKA Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas HSKA's P/E ratio is -62.49. In terms of profitability, FOCL's ROE is -1.38%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, FOCL is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check HSKA's competition here
CONMED Corporation (NYSE: CNMD)
FOCL vs CNMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CNMD has a market cap of 1.3B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CNMD trades at $43.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CNMD's P/E ratio is 9.51. In terms of profitability, FOCL's ROE is -1.38%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, FOCL is less volatile compared to CNMD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CNMD's competition here
IRadimed Corporation (NASDAQ: IRMD)
FOCL vs IRMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while IRMD trades at $97.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas IRMD's P/E ratio is 49.13. In terms of profitability, FOCL's ROE is -1.38%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, FOCL is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check IRMD's competition here
Artivion, Inc. (NYSE: AORT)
FOCL vs AORT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AORT trades at $25.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AORT's P/E ratio is 38.51. In terms of profitability, FOCL's ROE is -1.38%, compared to AORT's ROE of +0.03%. Regarding short-term risk, FOCL is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check AORT's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
FOCL vs TNDM Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while TNDM trades at $17.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas TNDM's P/E ratio is -15.53. In terms of profitability, FOCL's ROE is -1.38%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, FOCL is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
FOCL vs AVNS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AVNS trades at $24.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AVNS's P/E ratio is 27.76. In terms of profitability, FOCL's ROE is -1.38%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, FOCL is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check AVNS's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
FOCL vs SILK Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SILK's P/E ratio is -18.96. In terms of profitability, FOCL's ROE is -1.38%, compared to SILK's ROE of -0.35%. Regarding short-term risk, FOCL is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
FOCL vs FNA Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas FNA's P/E ratio is -19.83. In terms of profitability, FOCL's ROE is -1.38%, compared to FNA's ROE of -0.35%. Regarding short-term risk, FOCL is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check FNA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
FOCL vs PRCT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PRCT has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PRCT trades at $19.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PRCT's P/E ratio is -10.56. In terms of profitability, FOCL's ROE is -1.38%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, FOCL is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PRCT's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
FOCL vs LMRI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while LMRI trades at $11.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas LMRI's P/E ratio is -21.67. In terms of profitability, FOCL's ROE is -1.38%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, FOCL is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check LMRI's competition here
InMode Ltd. (NASDAQ: INMD)
FOCL vs INMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, INMD has a market cap of 896.4M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while INMD trades at $15.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas INMD's P/E ratio is 10.00. In terms of profitability, FOCL's ROE is -1.38%, compared to INMD's ROE of +0.13%. Regarding short-term risk, FOCL is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INMD's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
FOCL vs CSII Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CSII's P/E ratio is -20.83. In terms of profitability, FOCL's ROE is -1.38%, compared to CSII's ROE of -0.14%. Regarding short-term risk, FOCL is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CSII's competition here
Bioventus Inc. (NASDAQ: BVS)
FOCL vs BVS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BVS has a market cap of 817M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BVS trades at $12.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BVS's P/E ratio is 16.08. In terms of profitability, FOCL's ROE is -1.38%, compared to BVS's ROE of +0.16%. Regarding short-term risk, FOCL is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BVS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
FOCL vs SIBN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SIBN has a market cap of 770.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SIBN trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SIBN's P/E ratio is -44.56. In terms of profitability, FOCL's ROE is -1.38%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, FOCL is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SIBN's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
FOCL vs SSII Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SSII has a market cap of 742.5M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SSII trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SSII's P/E ratio is -72.36. In terms of profitability, FOCL's ROE is -1.38%, compared to SSII's ROE of -0.23%. Regarding short-term risk, FOCL is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SSII's competition here
CeriBell, Inc. (NASDAQ: CBLL)
FOCL vs CBLL Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CBLL has a market cap of 710.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CBLL trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CBLL's P/E ratio is -11.48. In terms of profitability, FOCL's ROE is -1.38%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, FOCL is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CBLL's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
FOCL vs TCMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, TCMD has a market cap of 648.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while TCMD trades at $28.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas TCMD's P/E ratio is 32.66. In terms of profitability, FOCL's ROE is -1.38%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, FOCL is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TCMD's competition here
Cerus Corporation (NASDAQ: CERS)
FOCL vs CERS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CERS has a market cap of 627.2M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CERS trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CERS's P/E ratio is -62.48. In terms of profitability, FOCL's ROE is -1.38%, compared to CERS's ROE of -0.15%. Regarding short-term risk, FOCL is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CERS's competition here
BrainsWay Ltd. (NASDAQ: BWAY)
FOCL vs BWAY Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BWAY has a market cap of 617M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BWAY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BWAY's P/E ratio is 39.96. In terms of profitability, FOCL's ROE is -1.38%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, FOCL is less volatile compared to BWAY. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BWAY's competition here
Surmodics, Inc. (NASDAQ: SRDX)
FOCL vs SRDX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SRDX's P/E ratio is -34.66. In terms of profitability, FOCL's ROE is -1.38%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, FOCL is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
FOCL vs CTKB Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CTKB has a market cap of 596.6M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CTKB trades at $4.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CTKB's P/E ratio is -35.54. In terms of profitability, FOCL's ROE is -1.38%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, FOCL is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check CTKB's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
FOCL vs APEN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas APEN's P/E ratio is -9.43. In terms of profitability, FOCL's ROE is -1.38%, compared to APEN's ROE of -0.85%. Regarding short-term risk, FOCL is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check APEN's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
FOCL vs NPCE Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, NPCE has a market cap of 548.2M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while NPCE trades at $16.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas NPCE's P/E ratio is -27.72. In terms of profitability, FOCL's ROE is -1.38%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, FOCL is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check NPCE's competition here
ZimVie Inc. (NASDAQ: ZIMV)
FOCL vs ZIMV Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, FOCL's ROE is -1.38%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, FOCL is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ZIMV's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
FOCL vs KIDS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, KIDS has a market cap of 493.5M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while KIDS trades at $19.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas KIDS's P/E ratio is -18.66. In terms of profitability, FOCL's ROE is -1.38%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, FOCL is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check KIDS's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
FOCL vs OFIX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, OFIX has a market cap of 468.1M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while OFIX trades at $11.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas OFIX's P/E ratio is -47.17. In terms of profitability, FOCL's ROE is -1.38%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, FOCL is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check OFIX's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
FOCL vs CLPT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CLPT has a market cap of 454.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CLPT trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CLPT's P/E ratio is -15.00. In terms of profitability, FOCL's ROE is -1.38%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, FOCL is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CLPT's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
FOCL vs PACB Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PACB has a market cap of 447.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PACB trades at $1.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PACB's P/E ratio is -2.94. In terms of profitability, FOCL's ROE is -1.38%, compared to PACB's ROE of -4.88%. Regarding short-term risk, FOCL is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PACB's competition here
Varex Imaging Corporation (NASDAQ: VREX)
FOCL vs VREX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, VREX has a market cap of 444.2M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while VREX trades at $10.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas VREX's P/E ratio is 11.11. In terms of profitability, FOCL's ROE is -1.38%, compared to VREX's ROE of -0.18%. Regarding short-term risk, FOCL is less volatile compared to VREX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check VREX's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
FOCL vs DCTH Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, DCTH has a market cap of 442.2M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while DCTH trades at $12.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas DCTH's P/E ratio is 1281.00. In terms of profitability, FOCL's ROE is -1.38%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, FOCL is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check DCTH's competition here
Electromed, Inc. (AMEX: ELMD)
FOCL vs ELMD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ELMD has a market cap of 348.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ELMD trades at $42.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ELMD's P/E ratio is 36.00. In terms of profitability, FOCL's ROE is -1.38%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, FOCL is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ELMD's competition here
Carlsmed, Inc. (NASDAQ: CARL)
FOCL vs CARL Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CARL has a market cap of 317M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CARL trades at $11.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CARL's P/E ratio is -4.65. In terms of profitability, FOCL's ROE is -1.38%, compared to CARL's ROE of -0.62%. Regarding short-term risk, FOCL is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CARL's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
FOCL vs AVR Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, AVR has a market cap of 310.9M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while AVR trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas AVR's P/E ratio is -3.79. In terms of profitability, FOCL's ROE is -1.38%, compared to AVR's ROE of -1.24%. Regarding short-term risk, FOCL is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check AVR's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
FOCL vs SMLR Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SMLR's P/E ratio is 3.92. In terms of profitability, FOCL's ROE is -1.38%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, FOCL is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check SMLR's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
FOCL vs TMCI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, TMCI has a market cap of 279M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while TMCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas TMCI's P/E ratio is -4.57. In terms of profitability, FOCL's ROE is -1.38%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, FOCL is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TMCI's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
FOCL vs SGHT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SGHT has a market cap of 273.7M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SGHT trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SGHT's P/E ratio is -7.08. In terms of profitability, FOCL's ROE is -1.38%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, FOCL is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SGHT's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
FOCL vs MGRM Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas MGRM's P/E ratio is -12.00. In terms of profitability, FOCL's ROE is -1.38%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, FOCL is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check MGRM's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
FOCL vs CATX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CATX has a market cap of 230.7M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CATX trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CATX's P/E ratio is -2.12. In terms of profitability, FOCL's ROE is -1.38%, compared to CATX's ROE of -0.42%. Regarding short-term risk, FOCL is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CATX's competition here
RxSight, Inc. (NASDAQ: RXST)
FOCL vs RXST Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, RXST has a market cap of 229.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while RXST trades at $5.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas RXST's P/E ratio is -7.71. In terms of profitability, FOCL's ROE is -1.38%, compared to RXST's ROE of -0.17%. Regarding short-term risk, FOCL is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check RXST's competition here
Nevro Corp. (NYSE: NVRO)
FOCL vs NVRO Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas NVRO's P/E ratio is -1.91. In terms of profitability, FOCL's ROE is -1.38%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, FOCL is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check NVRO's competition here
Picard Medical, Inc. (AMEX: PMI)
FOCL vs PMI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PMI has a market cap of 220.4M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PMI trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PMI's P/E ratio is -0.12. In terms of profitability, FOCL's ROE is -1.38%, compared to PMI's ROE of +4.99%. Regarding short-term risk, FOCL is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PMI's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
FOCL vs SENS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, SENS has a market cap of 213.6M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while SENS trades at $5.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas SENS's P/E ratio is -2.56. In terms of profitability, FOCL's ROE is -1.38%, compared to SENS's ROE of -1.30%. Regarding short-term risk, FOCL is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check SENS's competition here
Profound Medical Corp. (NASDAQ: PROF)
FOCL vs PROF Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, PROF has a market cap of 207.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while PROF trades at $6.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas PROF's P/E ratio is -5.52. In terms of profitability, FOCL's ROE is -1.38%, compared to PROF's ROE of -0.70%. Regarding short-term risk, FOCL is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check PROF's competition here
Anika Therapeutics, Inc. (NASDAQ: ANIK)
FOCL vs ANIK Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ANIK has a market cap of 202.9M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ANIK trades at $15.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ANIK's P/E ratio is 31.12. In terms of profitability, FOCL's ROE is -1.38%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, FOCL is less volatile compared to ANIK. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check ANIK's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
FOCL vs BSGM Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas BSGM's P/E ratio is -5.81. In terms of profitability, FOCL's ROE is -1.38%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, FOCL is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check BSGM's competition here
Quanterix Corporation (NASDAQ: QTRX)
FOCL vs QTRX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, QTRX has a market cap of 182.1M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while QTRX trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas QTRX's P/E ratio is -2.42. In terms of profitability, FOCL's ROE is -1.38%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, FOCL is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check QTRX's competition here
Inogen, Inc. (NASDAQ: INGN)
FOCL vs INGN Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, INGN has a market cap of 180.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while INGN trades at $6.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas INGN's P/E ratio is -7.32. In terms of profitability, FOCL's ROE is -1.38%, compared to INGN's ROE of -0.13%. Regarding short-term risk, FOCL is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check INGN's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
FOCL vs MDGS Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas MDGS's P/E ratio is -0.27. In terms of profitability, FOCL's ROE is -1.38%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, FOCL is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check MDGS's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
FOCL vs TLSI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, TLSI has a market cap of 162.6M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while TLSI trades at $4.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas TLSI's P/E ratio is -2.55. In terms of profitability, FOCL's ROE is -1.38%, compared to TLSI's ROE of +1.63%. Regarding short-term risk, FOCL is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check TLSI's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
FOCL vs QIPT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas QIPT's P/E ratio is -15.87. In terms of profitability, FOCL's ROE is -1.38%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, FOCL is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check QIPT's competition here
CVRx, Inc. (NASDAQ: CVRX)
FOCL vs CVRX Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, CVRX has a market cap of 130.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while CVRX trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas CVRX's P/E ratio is -2.43. In terms of profitability, FOCL's ROE is -1.38%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, FOCL is less volatile compared to CVRX. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check CVRX's competition here
Avita Medical Inc. (NASDAQ: RCEL)
FOCL vs RCEL Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, RCEL has a market cap of 126.7M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while RCEL trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas RCEL's P/E ratio is -3.25. In terms of profitability, FOCL's ROE is -1.38%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, FOCL is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check RCEL's competition here
iCAD, Inc. (NASDAQ: ICAD)
FOCL vs ICAD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ICAD's P/E ratio is -20.37. In terms of profitability, FOCL's ROE is -1.38%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, FOCL is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ICAD's competition here
Owlet, Inc. (NYSE: OWLT)
FOCL vs OWLT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, OWLT has a market cap of 101.1M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while OWLT trades at $5.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas OWLT's P/E ratio is -39.93. In terms of profitability, FOCL's ROE is -1.38%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, FOCL is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check OWLT's competition here
Solana Company (NASDAQ: HSDT)
FOCL vs HSDT Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, HSDT has a market cap of 99.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while HSDT trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas HSDT's P/E ratio is -0.02. In terms of profitability, FOCL's ROE is -1.38%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, FOCL is less volatile compared to HSDT. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check HSDT's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
FOCL vs HJLI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas HJLI's P/E ratio is N/A. In terms of profitability, FOCL's ROE is -1.38%, compared to HJLI's ROE of -0.66%. Regarding short-term risk, FOCL is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check HJLI's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
FOCL vs LUCD Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, LUCD has a market cap of 97.2M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while LUCD trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas LUCD's P/E ratio is -2.57. In terms of profitability, FOCL's ROE is -1.38%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, FOCL is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check LUCD's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
FOCL vs ASXC Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas ASXC's P/E ratio is -1.12. In terms of profitability, FOCL's ROE is -1.38%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, FOCL is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for FOCL.Check ASXC's competition here
Rapid Micro Biosystems, Inc. (NASDAQ: RPID)
FOCL vs RPID Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, RPID has a market cap of 93.8M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while RPID trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas RPID's P/E ratio is -1.85. In terms of profitability, FOCL's ROE is -1.38%, compared to RPID's ROE of -1.32%. Regarding short-term risk, FOCL is less volatile compared to RPID. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check RPID's competition here
QT Imaging Holdings, Inc. (NASDAQ: QTI)
FOCL vs QTI Comparison July 2026
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FOCL stands at 203.7M. In comparison, QTI has a market cap of 89M. Regarding current trading prices, FOCL is priced at $5.44 on the NASDAQ, while QTI trades at $3.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FOCL currently has a P/E ratio of -6.99, whereas QTI's P/E ratio is -4.82. In terms of profitability, FOCL's ROE is -1.38%, compared to QTI's ROE of -63.31%. Regarding short-term risk, FOCL is less volatile compared to QTI. This indicates lower risk in terms of short-term price fluctuations for FOCL.Check QTI's competition here